Abstract
Respiratory syncytial virus (RSV) is among the most common causes of lower respiratory tract infections (LRTI) in children, with poorer outcomes more likely in immunocompromised hosts. The Immunodeficiency Scoring Index (ISI) to stratify the risk of severe disease has been developed and applied in adults undergoing transplantation with RSV infections. However, such scores are not available for children undergoing transplantation. Using a retrospective multi-site study, we developed an ISI score index for predicting RSV disease progression in pediatric transplant recipients. Pediatric (< 18 years old at transplant) HCT and SOT recipients at 22 U.S. transplant centers who underwent transplant (2010-2019) and had RSV detected within 365 days of conditioning or transplant were included. De-identified data were entered by the participating sites in the REDCap database. The ISI score criteria are listed in Table 1. The cases were summarized using the ISI score. Progression to LRTI and death related to RSV were summarized using the ISI score. Fisher’s exact and non-parametric tests were used to compare ISI risk categories with the outcomes of interest (progression to LRTI and RSV-related mortality). In total, 352 patients were included in this analysis (220 HCT and 132 SOT). The majority were male (55%) and Caucasian/white (58.2%), with a median age of 4 years (range, 0 – 17 years). In total, 27 cases progressed to LRTI, and three deaths were related to RSV. The median ISI score was 1 (range: 0–10). The cases were categorized into low (245, 69.6%), moderate (81, 23%), or high (26, 7.4%) ISI risk categories (Table 1). The ISI score categories did not significantly predict progression to LRTI- or RSV-related deaths. RSV is associated with poor outcomes in immunocompromised pediatric patients. Development of immunodeficiency scoring index criteria could prove helpful in categorizing the risk for pediatric patients. Additional work is needed to develop a scoring system that effectively predicts pediatric immunocompromised patients at the greatest risk of RSV-related morbidity and mortality. Further investigation of our data from this large multi-site study is needed to assess all potential risk factors and scoring criteria definitions. Table 1. Immunodeficiency Scoring Index ANC: absolute neutrophil count; ALC: absolute lymphocyte count; GVHD: graft versus host disease Table 1. Immunodeficiency Scoring Index ANC: absolute neutrophil count; ALC: absolute lymphocyte count; GVHD: graft versus host disease